{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:57:15Z","timestamp":1794628635807,"version":"4.9.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Volatile anesthetics have been historically preferred for cardiac anesthesia, but the evidence for their superiority to intravenous agents is mixed. We conducted a survey to better understand the current state of practice and the rationale behind provider preferences for anesthesia for cardiac surgery with cardiopulmonary bypass. We hypothesized that anesthetic preference would vary considerably among surveyed providers without a clear majority, as would the rationale behind those preferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Email invitations were sent to members of the Society of Cardiovascular Anesthesiologists, who were asked to identify the anesthetics or sedatives they typically prefer to administer during induction, prebypass, bypass, postbypass, and postoperative periods and why they prefer those agents. Members\u2019 beliefs regarding the importance of anesthetics on postoperative outcomes were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Invitations were sent on 2 separate dates to 3328 and 3274 members, of whom 689 (21%) responded. The median (interquartile range [IQR]) respondent age was 45 (37\u201356) years, 79% were men, and 75% were fellowship trained. The most frequently chosen drug for induction was propofol (80%). Isoflurane was the most frequently selected primary agent for the prebypass (57%), bypass (62%), and postbypass periods (50%). Sevoflurane was the second most frequently selected (30%; 17%, and 24%, respectively). Propofol was the third most frequently selected agent for the bypass (14%) and postbypass periods (17%). Ease of use was the most frequently selected reason for administering isoflurane and sevoflurane for each period. During bypass, the second most frequently selected rationale for using isoflurane and sevoflurane was institutional practice. A total of 76% responded that the perfusionist typically delivers the bypass anesthetic. Ischemic preconditioning, organ protection, and postoperative cognitive function were infrequently selected as rationales for preferring the volatile anesthetics. Most respondents (73%) think that anesthetics have organ-protective properties, especially isoflurane (74%) and sevoflurane (59%), and 72% believed that anesthetic choice contributes to patient outcome. The median (IQR) agreement (0 = strongly disagree to 100 = strongly agree) was 72 (63\u201385) for the statement that \u201cinhaled anesthetics are an optimal maintenance anesthetic for cardiac surgery.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In a survey of cardiac anesthesiologists, a majority of respondents indicated that they prefer volatile anesthetics for maintenance of anesthesia, that anesthetic selection impacts patient outcomes, and that volatile anesthetics have organ-protective properties. The members\u2019 rationales for preferring these agents possibly reflect that practical considerations, such as ease of use, effectiveness, and institutional practice, also influence anesthetic selection during cardiac surgery in addition to considerations such as organ protection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006147","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T08:00:58Z","timestamp":1657612858000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Anesthetic Preferences for Cardiac Anesthesia: A Survey of the Society of Cardiovascular Anesthesiologists"],"prefix":"10.1213","volume":"136","author":[{"given":"Brian P.","family":"O\u2019Gara","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla Y.","family":"Beydoun","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abirami","family":"Kumaresan","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Keck Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad","family":"Shaefi","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1051\/ject\/200537227","article-title":"General anesthesia in cardiac surgery: a review of drugs and practices.","volume":"37","author":"Alwardt","year":"2005","journal-title":"J Extra Corpor Technol"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1213\/ANE.0000000000000612","article-title":"Anesthetic management during cardiopulmonary bypass: a systematic review.","volume":"120","author":"Barry","year":"2015","journal-title":"Anesth Analg"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.jtcvs.2014.10.005","article-title":"Volatile anesthetics in cardiac surgery: renoprotective, cardioprotective, neither, or both?","volume":"148","author":"Andersen","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e014629","DOI":"10.1136\/bmjopen-2016-014629","article-title":"Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis.","volume":"7","author":"Chen","year":"2017","journal-title":"BMJ Open"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.jvca.2007.02.013","article-title":"Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials.","volume":"21","author":"Landoni","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines.","volume":"64","author":"Fleisher","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/j.jvca.2020.10.036","article-title":"A comparison of volatile anesthesia and total intravenous anesthesia (TIVA) effects on outcome from cardiac surgery: a systematic review and meta-analysis.","volume":"35","author":"Beverstock","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/ALN.0000000000003236","article-title":"Volatile anesthetics versus propofol for cardiac surgery with cardiopulmonary bypass: meta-analysis of randomized trials.","volume":"132","author":"Bonanni","year":"2020","journal-title":"Anesthesiology"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/bja\/aex087","article-title":"Efficacy and safety of inhaled anaesthetic for postoperative sedation during mechanical ventilation in adult cardiac surgery patients: a systematic review and meta-analysis.","volume":"118","author":"Spence","year":"2017","journal-title":"Br J Anaesth"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/bja\/ael149","article-title":"Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis.","volume":"97","author":"Symons","year":"2006","journal-title":"Br J Anaesth"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/bja\/aeu290","article-title":"Volatile compared with total intravenous anaesthesia in patients undergoing high-risk cardiac surgery: a randomized multicentre study.","volume":"113","author":"Landoni","year":"2014","journal-title":"Br J Anaesth"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5603\/AIT.a2018.0012","article-title":"Comparison of propofol-based versus volatile-based anaesthesia and postoperative sedation in cardiac surgical patients: a prospective, randomized, study.","volume":"50","author":"W\u0105sowicz","year":"2018","journal-title":"Anaesthesiol Intensive Ther"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1056\/NEJMoa1816476","article-title":"Volatile anesthetics versus total intravenous anesthesia for cardiac surgery.","volume":"380","author":"Landoni","year":"2019","journal-title":"N Engl J Med"},{"key":"R15-20250502","first-page":"1","article-title":"Council directive 93\/42\/EEC concerning medical devices.","volume":"169","author":"Council","year":"1993","journal-title":"Off J Eur Commun, Luxembourg"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.jvca.2009.01.022","article-title":"Volatile anesthetics reduce mortality in cardiac surgery.","volume":"23","author":"Bignami","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/j.jvca.2012.10.011","article-title":"Myocardial protection by volatile anesthetics in patients undergoing cardiac surgery: a critical review of the laboratory and clinical evidence.","volume":"27","author":"Pagel","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/ALN.0000000000001120","article-title":"Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis.","volume":"124","author":"Uhlig","year":"2016","journal-title":"Anesthesiology"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0163278707311874","article-title":"Nonresponse bias and cost-effectiveness in a Norwegian survey of family physicians.","volume":"31","author":"Bjertnaes","year":"2008","journal-title":"Eval Health Prof"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amjcard.2010.02.026","article-title":"Radiation safety among cardiology fellows.","volume":"106","author":"Kim","year":"2010","journal-title":"Am J Cardiol"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2288-11-126","article-title":"A randomised trial and economic evaluation of the effect of response mode on response rate, response bias, and item non-response in a survey of doctors.","volume":"11","author":"Scott","year":"2011","journal-title":"BMC Med Res Methodol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:33:14Z","timestamp":1786113194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006147","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,11]]}}}